As legal scrutiny and regulatory uncertainty continue to surround the topic of 340B, pharmacy leaders must stay up to date on the latest developments to protect program integrity and ensure compliance. The policy landscape is shifting all the time,  with changes to contract pharmacy arrangements, manufacturer restrictions, and audit practices reshaping how 340B is implemented across IDNs.

Join Mark Ogunsusi and explore a timely update on the evolution and advancement of 340B, its impact on your organization, and strategies for adapting to a program that continues to face intense external pressure.

Learning Objectives:
1. Outline recent legal and regulatory developments impacting the 340B program and their implications for covered entities.
2. Identify high-risk areas for non-compliance within 340B operations and contract pharmacy relationships.
3. Evaluate the impact of manufacturer restrictions and federal oversight on 340B savings and access.
4. Formulate strategies to maintain program integrity and optimize participation amid a shifting legal environment.